Renal hemodynamics in rats with myocardial infarction: Selective antagonism of angiotensin receptor subtypes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 6 40-6, 1996, Pages

  Mento, Peter F ^a   Maita, Mary E ^b   Wilkes, Barry M ^b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

congestive heart failure; losartan; microspheres; PD 123319

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; CERIUM 141; CHROMIUM 51; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; MICROSPHERE; RECEPTOR SUBTYPE; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HEART INDEX; HEART INFARCTION; HEART OUTPUT; INTRACARDIAC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; RENOVASCULAR DISEASE;

EID: 0030462808     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.6.h2306     Document Type: Article

References (30)

1. 1 receptor mRNA in rat kidney. Kidney Int. 46: 973-979, 1994.
2. Chansel, D., S. Czekalski, P. Pham, and R. Ardaillou. Characterization of angiotensin II receptor subtypes in human glomeruli and mesangial cells. Am. J. PhysioL 262 (Renal Fluid Electrolyte Physiol. 31): F432-F441, 1992.
3. Dzau, V. J. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 77, Suppl. I: I-4-I-13, 1988.
4. Hein, L., G. S. Barsh, R. E. Pratt, V. J. Dzau, and B. K. Kobilka. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature Lond. 377: 744-747, 1995.
5. Ichiki, T., P.A. Labosky, C. Shiota, S. Okuyama, Y. Imagawa, A. Fogo, F. Niimura, I. Ichikawa, B. L. M. Hogan, and T. Inagami. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature Lond. 377: 748-750, 1995
6. Iwai, N., Y. Yamano, S. Chaki, F. Konishi, S. Bardhan, C. Tibbetts, K. Sasaki, M. Hasegawa, Y. Matsuda, and T. Inagami. Rat angiotensin II receptor: cDNA sequence and regulation of the gene expression. Biochem. Biophys. Res. Commun. 177: 299-304, 1991.
7. Janiak, P., A. Pillon, J.-F. Prost, and J.-P. Vilaine. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension Dallas 20: 737-745, 1992.
8. Kakar, S. S., J. C. Sellers, D. C. Devor, L. C. Musgrove, and J. D. Neill. Angiotensin II type-1 receptor subtype cDNAs: differential tissue expression and hormonal regulation. Biochem. Biophys. Res. Commun. 183: 1090-1096, 1992.
9. 2 subtype-specific angiotensin II ligands. J. Pharmacol. Exp. Ther. 262: 1154-1160, 1992.
10. Lindpainter, K., W. Lu, N. Niedermajer, B. Schieffer, H. Just, D. Ganten, and H. Drexler. Selective activation of cardiac angiotensinogen gene expression in post-infarction remodeling in the rat. J. Mol. Cell. Cardiol. 25: 133-143, 1993.
11. Lo, M., K.-L. Liu, P. Lantelme, and J. Sassard, Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. J. Clin. Invest. 95: 1394-1397, 1995.
12. 2-receptor subtypes in hypertrophied rat hearts. Am. J. Physiol. 267 (Heart Circ. Physiol. 36): H844-H852, 1994.
13. 2 receptor ligands CGP 42112 and PD 123319 after blockade of the renin-angiotensin system. Eur. J. Pharmacol. 259: 27-36, 1994.
14. Meggs, L. G., J. Coupet, H. Huang, W. Cheng, P. Li, J. M. Capasso, C. J. Homey, and P. Anversa. Regulation of angiotensin II receptors on ventricular myocytes after myocardial infarction in rats. Circ. Res. 72: 1149-1162, 1993.
15. Mento, P. F., M. E. Maita, W. R. Murphy, W. F. Holt, and B. M. Wilkes. Comparison of angiotensin converting enzyme and renin inhibition in rats following myocardial infarction. J. Cardiovasc. Pharmacol. 21: 791-796, 1993.
16. Mento, P. F., and B. M. Wilkes. Azotemia during chronic converting enzyme inhibition with enalapril in sodium depleted rats: role of renal circulatory changes. J. Cardiovasc. Pharmacol. 8: 670-675, 1986.
17. Murphy, T. J., R. W. Alexander, K. K. Griendling, M. S. Runge, and K. E. Berstein. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature Lond. 351: 233-236, 1991.
18. 1 receptor: gain-of-function study using gene transfer. Proc. Natl. Acad. Sci. USA 92: 10663-10667, 1995.
19. Pfeffer, J. M., T. A. Fischer, and M. A. Pfeffer. Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction. Anna. Rev. Physiol. 57: 805-826, 1995.
20. Pfeffer, J. M., M. A. Pfeffer, and E. Braunwald. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ. Res. 57: 84-95, 1985.
21. Pfeffer, M. A., J. M. Pfeffer, C. Fishbein, P. J. Fletcher, J. Spadaro, A. Kloner, and E. Braunwald. Myocardial infarct size and ventricular function in rats. Circ. Res. 44: 503-512, 1979.
22. Schunkert, H., J. R. Ingelfinger, A. T. Hirsch, S. S. Tang, S. E. Litwin, C. E. Talsness, and D. J. Dzau. Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure. J. Clin. Invest. 90: 1523-1529, 1992.
23. Scicli, A. G. Increases in cardiac kinins as a new mechanism to protect the heart. Hypertension Dallas 23: 419-421, 1994.
24. Selye, H., E. Bajusz, S. Grasso, and P. Mendell. Simple techniques for the surgical occlusion of coronary vessels in the rat. Angiology 11: 398-407, 1960.
25. Smith, R. D., A. T. Chin, P. C. Wong, W. F. Herblin, and P. B. M. W. M. Timmermans. Pharmacology of nonpeptide angiotensin II receptor antagonists. Annu. Rev. Pharmacol. Toxicol. 32: 135-165, 1992.
26. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N. Engl. J. Med. 325: 293-302, 1991.
27. Sweet, C. S., S. E. Emmert, I. I. Stabilito, and L. G. T. Ribeiro. Increased survival in rats with congestive heart failure treated with enalapril. J. Cardiovasc. Pharmacol. 10: 636-642, 1987.
28. Wong, P. C., D. D. Christ, and P. B. M. W. M. Timmermans. Enhancement of losartan (Dup 753)-induced angiotensin II receptor antagonism by PD-123177 in rats. Eur. J. Pharmacol. 220: 267-270, 1992.
29. Wong, P. C., S. D. Hart, A. M. Zaspel, A. T. Chiu, R. J. Ardecky, R. D. Smith, and P. B. M. W. M. Timmermans. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD 123,177 (AII-2). J. Pharmacol. Exp. Ther. 255. 584-592, 1990.
30. Wong, P. C., W. A. Price, A. T. Chiu, J. V. Duncia, D. J. Carini, R. R. Wexler, A. L. Johnson, and P. B. M. W. M. Timmermans. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent. J. Pharmacol. Exp. Ther. 252: 726-732, 1995.